1-3 of 3
Anders EA Dahm
Close
Sort by
Journal Articles

Low Dose Apixaban As Secondary Prophylaxis for Venous Thromboembolism in Cancer Patients, 30 Months Follow-up

Trine-Lise Hannevik, Herish Garresori, Jorunn Brekke, Tone Ronnaug Enden, Hege Froen, Eva-Marie Jacobsen, Petter Quist-Paulsen, Alina Carmen Porojnicu, Anne Hansen Ree, Dag Torfoss, Elin Velle, Hilde Skuterud Wik, Waleed Ghanima, Per Morten Sandset, Anders EA Dahm
Journal: Blood
Blood (2021) 138 (Supplement 1): 3231.
https://doi.org/10.1182/blood-2021-148105
Published: 2021
Journal Articles

Tissue Factor Pathway Inhibitor Enhances Transendothelial Migration of Chronic Lymphocytic Leukemia Cells through Binding to Glypican-3

Xueyan Cui, MD PhD, Geir Erland Tjønnfjord, MD DMsc, Sandip Kanse, PhD, Nina Iversen, PhD, Anders EA Dahm, MD PhD, Christiane Filion Myklebust, Ling Sun, MD PhD, Zhong Xing Jiang, MD PhD, Mitchell Ho, PhD, Per Morten Sandset
Journal: Blood
Blood (2018) 132 (Supplement 1): 2452.
https://doi.org/10.1182/blood-2018-99-111241
Published: 2018
Journal Articles

Safety of D-Dimer As a Stand-Alone Test for the Exclusion of Deep Vein Thrombosis Compared to Other Strategies

Synne Fronas, MD, Hilde Skuterud Wik, Anders EA Dahm, MD PhD, Camilla Tøvik Jørgensen, Jostein Gleditsch, Nezar Raouf, Erik A Klok, MD PhD, Waleed Ghanima
Journal: Blood
Blood (2018) 132 (Supplement 1): 2517.
https://doi.org/10.1182/blood-2018-99-113831
Published: 2018